Loading company…
Ucaneo Biotech develops electrochemical direct air capture technology to remove carbon dioxide from the air.
Founded in 2022 and based in Berlin, Ucaneo Biotech develops biomimetic direct air capture technology that removes CO2 through an electrochemical process. It also produces carbon credits. In September 2024, the company received grant funding as part of a USD 6.75 million seed and grant round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in